Company Profiles

driven by the PitchBook Platform

Abexxa Biologics

Abexxa Biologics
2015 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Seed LATEST DEAL TYPE
$1.25M LATEST DEAL AMOUNT
$1.25M TOTAL AMOUNT RAISED
Description

Developer of antibody based therapeutics based on immunotherapy research.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Healthcare
Primary Office
NanoFab Building, 500 South Cooper Street
Suite 203
Arlington, TX 76019
United States
+1 (512) 497-5742
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Abexxa Biologics’s full profile, request a free trial.

Abexxa Biologics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 15-Sep-2016 $1.25M $1.25M 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Abexxa Biologics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Seed 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table request access »

Abexxa Biologics Executive Team (2)

Name Title Board
Seat
Contact
Info
Debra Weidanz President and Director
Jon Weidanz Ph.D President & Director

Abexxa Biologics Board Members (1)

Name Representing Role Since Contact
Info
Martin Heidecker Abexxa Biologics Board Member 000 0000